ClinicalTrials.gg
CompletedNCT05000528ETP-INSOMNIEUpdated Oct 21, 2026

Evaluation of the Effectiveness of Patient Therapeutic Education on Chronic Insomnia

An interventional study of therapeutic education and Actimetry in Sleep Initiation and Maintenance Disorders, sponsored by Centre Hospitalier Universitaire de Nīmes. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-21.

Sponsored by Centre Hospitalier Universitaire de Nīmes · Not applicable, Interventional, and Treatment

How we know

Updated Oct 21, 2026Now CompletedPrimary completion moved+4 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 76 studies in Sleep Initiation and Maintenance Disorders with a site in France — 19 open to participants now, 19 under way, 1 of them phase 3. Sleep Initiation and Maintenance Disorders · France.

Enrollment
46th of 60
44 · median 69
Started
2022
with 6 others
No phase
37 of 76
12 open now
Registered
46th of 76
by date

Among the 76 studies in Sleep Initiation and Maintenance Disorders with a site in France, this one is the 46th largest by enrollment of the 60 interventional ones that give a count, is one of 7 that started in 2022, is one of 37 with no phase, and was the 46th registered.

Sleep Initiation and Maintenance Disorders

2,738 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 735 are open to participants now.

Browse Sleep Initiation and Maintenance Disorders studies →

Open to participants now

19 of the 76 studies in Sleep Initiation and Maintenance Disorders with a site in France are open now. Recruiting first, the newest first:

14 more — sign in →

All 19 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 394 Sleep Initiation and Maintenance Disorders studies recruiting now, 156 (40%) set no upper age limit and 208 (53%) stop at 75 or younger; 61 take children under 18; 112 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 76 studies in Sleep Initiation and Maintenance Disorders with a site in France, or all of them as a file.
02

Study summary

20 to 30% of the general population suffers from chronic insomnia. Cognitive behavioral therapy (CBT) is the first-line treatment, but unfortunately its implementation is complex. Long waiting times for a consultation / exploration, too short a consultation period, non-reimbursement of specialists and a lack of trained staff make the current care of insomniac patients difficult. Patients are thus treated late, often with heavy drug treatment, dependence on sleeping pills, difficult withdrawal and / or reactive mood disorders. The treatment is therefore limited to advice on sleep hygiene and a restriction of time spent in bed without ultimately intervening in the cognitive domain. Therapeutic education consists of empowering the patient in the management of chronic insomnia through group education workshops. The patient learns the principles of normal sleep, the way in which sleep evolves with aging, the dangers of treatments as well as the rules of sleep hygiene and the behaviors to modify to sleep well. In addition to benefiting from sharing of experience with other patients, therapeutic education makes the care pathway smoother and considerably reduces the long waiting times of the traditional care pathway in consultation.

The study investigators hypothesize that therapeutic education is more effective as a treatment for chronic insomnia than traditional management in individualized consultation (IC). Thus, therapeutic education could constitute an effective alternative to CBT.

03

Conditions studied

  • Sleep Initiation and Maintenance Disorders
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • The patient must have given their free and
  • The patient must be a member or beneficiary of a health insurance plan
  • Patient must understand and read French
  • Patient with ICSD-3 diagnostic criteria for chronic insomnia: ISI score > 14/28.

Exclusion criteria

Exclusion Criteria:

  • Patient with cognitive impairment as assessed by the investigator
  • Patient with shift work
  • Patients scoring > 10/24 on the Epworth sleepiness scale
  • Patient suffering from medical or psychiatric illnesses which may, in the opinion of the investigator, compromise the subject's state of health or ability to participate in the study.
  • Patient with chronic alcohol consumption or drug abuse
  • Patient unable to express consent.
  • Pregnant, parturient or breastfeeding patient.
  • The subject is participating in a category 1 interventional study, or is in a period of exclusion determined by a previous study
  • It is impossible to give the subject informed information
  • The patient is under safeguard of justice or state guardianship
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
44 participants (actual)

Study arms

  • Experimental
    Therapeutic education

    Other: therapeutic education · Other: Actimetry

  • Active comparator
    Individualized consultation

    Other: Actimetry

Interventions

  • Othertherapeutic education

    In groups of 5-6, patients will have a one-day therapeutic training session comprising 4 workshops: how to create a sleep agenda; normal sleep; sleep hygiene; medical treatments.

  • OtherActimetry

    once from inclusion for 2 weeks, second for 2 weeks starting 2 weeks after intervention

06

What researchers measure

Primary outcomes

  1. Improvement in chronic insomnia between groups

    Change in Insomnia Severity Index (ISI) score (Score between 0 - 28) from inclusion

    Time frame: Day 28

Secondary outcomes

  1. Change in total sleeping time between groups

    Change in total sleeping time (minutes) from inclusion

    Time frame: Day 28

  2. Change in time in bed between groups

    Change in time in bed (minutes) from inclusion

    Time frame: Day 28

  3. Change in effective sleep

    Time between going to bed and falling asleep (minutes). Average time for the 2 weeks following inclusion versus the 2 weeks preceding the study end measured by actimetry bracelet

    Time frame: Day 28

  4. Change in sleep latency

    % total sleeping time / time in bed. Average time for the 2 weeks following inclusion versus the 2 weeks preceding the study end measured by actimetry bracelet

    Time frame: Day 28

  5. Change in intra-sleep time

    Change in time between going to bed and falling asleep (minutes) since inclusion, data collected from patient sleep agenda

    Time frame: Day 28

  6. Change in anxiety since baseline between groups

    State-Trait Anxiety Inventory (STAI-Y). Self-questionnaire assessing anxiety-status (AE) reflecting the current emotional state and anxiety-trait (AT) reflecting the usual emotional state. Total score 20-80.

    Time frame: Day 28

  7. Change in depression since baseline between groups

    Beck Depression Inventory (BDI). The total score is obtained by adding the scores of the 13 items. This score will be between 0 and 63. The higher the score, the more depressed the subject is.

    Time frame: Day 28

  8. Change in quality of life since baseline

    Dysfunctional Beliefs and Attitudes about Sleep - 16 (DBAS-16). This self-questionnaire is composed of 16 items: Perceived consequences of insomnia (5 items), Worry/impotence about insomnia (6 items), Sleep expectations (2 items), Medication (3 items). The global score is an average of the scores of each item, ranging from 0 to 10. The higher the score, the more dysfunctional beliefs and attitudes about sleep

    Time frame: Day 28

  9. Use of hypnotic drugs between groups

    Yes/no for each type

    Time frame: Day 28

  10. Use of anxiolytic drugs between groups

    Yes/no for each type

    Time frame: Day 28

  11. Dose of any hypnotic drugs taken between groups

    Time frame: Day 28

  12. Dose of any anxiolytic drugs taken between groups

    Time frame: Day 28

  13. Completion of therapeutic education sessions of patients in the therapeutic education group

    Yes/no

    Time frame: Day 28

  14. Length of workshops in the therapeutic education group

    Minutes

    Time frame: Day 28

  15. Problems encountered during workshops of patients in the therapeutic education group

    Descriptive list made by investigator

    Time frame: Day 28

  16. Patient-reported reason for refusal to participate in the therapeutic education group

    Descriptive list of reasons given by the patient

    Time frame: Day 28

  17. Improvement in chronic insomnia between groups

    Change in Insomnia Severity Index (ISI) score (Score between 0 - 28) from inclusion

    Time frame: Month 4

  18. Change in anxiety since baseline between groups

    State-Trait Anxiety Inventory (STAI-Y). Self-questionnaire assessing anxiety-status (AE)

    Time frame: Month 4

  19. Change in depression since baseline between groups

    Beck Depression Inventory (BDI). The total score is obtained by adding the scores of the 13 items. This score will be between 0 and 63. The higher the score, the more depressed the subject is.

    Time frame: Month 4

  20. Change in quality of life since baseline

    Dysfunctional Beliefs and Attitudes about Sleep - 16 (DBAS-16). This self-questionnaire is composed of 16 items: Perceived consequences of insomnia (5 items), Worry/impotence about insomnia (6 items), Sleep expectations (2 items), Medication (3 items). The global score is an average of the scores of each item, ranging from 0 to 10. The higher the score, the more dysfunctional beliefs and attitudes about sleep

    Time frame: Month 4

07

Study locations

1 site
  • CHU de NIMES
    Nîmes, 30029, France
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Sep 2022 to primary completion in Mar 2024, 18 months.

Of 1,219 non-industry interventional studies with no phase under Sleep Initiation and Maintenance Disorders, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 35. This study's 18 months is above that.

Counting every sponsor, half of 1,297 studies reached it within 15 months; a quarter within 6 and three quarters within 34.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 21, 2026: primary completion Sep 2024 → Mar 2024 and completion Sep 2025 → Aug 2024.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jul 22, 2021
First posted
Aug 11, 2021
StartActual
Sep 30, 2022
Primary completionActual
Mar 30, 2024was Sep 2024
CompletionActual
Aug 29, 2024was Sep 2025
Last update
Oct 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Oct 21, 2026
Sites
1 site added, 1 site removed
Show site
  • CHU de NIMES · Nîmes, France
Show 1 removed
  • CHU de NIMES · Nimes, France
Oct 21, 2026
Primary completion
Sep 29, 2024→Mar 30, 2024
Oct 21, 2026
Study completion
Sep 29, 2025→Aug 29, 2024 (actual)
Oct 21, 2026
Show all 1 update
  1. Oct 21, 2026
    Recruiting→Completed
    1 site added, 1 site removed
    Show site
    • CHU de NIMES · Nîmes, France
    Show 1 removed
    • CHU de NIMES · Nimes, France
    Primary completion Sep 29, 2024→Mar 30, 2024
    Study completion Sep 29, 2025→Aug 29, 2024 (now actual)
    + 3 other changes: index terms, verification date and contact details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT05000528
Responsible party
Sponsor
First posted
Aug 11, 2021
Start date
Sep 30, 2022
Primary completion
Mar 30, 2024
Completion
Aug 29, 2024
Last update
Oct 21, 2026

Study contacts

Beatriz Abril
principal investigator · Centre Hospitalier Universitaire de Nīmes

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion